A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, March 16, 2020. (Photo: Xinhua)
No report of serious adverse reactions from 60,000 COVID-19 vaccine trial participants, official said on Tuesday.
CHINA
17:14, October 20, 2020
A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, March 16, 2020. (Photo: Xinhua)
No report of serious adverse reactions from 60,000 COVID-19 vaccine trial participants, official said on Tuesday.
We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies
